eCite Digital Repository

The risk of symptomatic venous thromboembolism in hospitalised patients with active cancer

Citation

Bereznicki, LRE and Peterson, GM and Krog, M and La Rosa, T and Marsden, KA and Lowenthal, RM and Rasmussen, M, The risk of symptomatic venous thromboembolism in hospitalised patients with active cancer, QUM - what does it really mean for you? The science, the policy and the practice. Final Program and Abstract Book., 14-16 May 2008, National Convention Centre, Canberra, Australia, pp. 96. (2008) [Conference Extract]


Preview
PDF
70Kb
  

Copyright Statement

National Prescribing Service.

Official URL: http://www.nps.org.au.

Abstract

Introduction Up to 75% of fatal pulmonary emboli in general hospitals occur in non-surgical patients immobilised by medical illness, Audits demonstrate that thromboprophylaxis is used in less than one-third of suitable patients, People with active cancer appear to be at significantly higher risk of symptomatic venous thromboembolism (VTE) than those without in epidemiological studies, Aim To determine the risk of symptomatic VTE, occurring during hospitalisation and within 90 days of discharge, in acutely ill patients with active cancer admitted to the Royal Hobart Hospital (RHH), Methods A retrospective cohort study was conducted, Medical records from patients admitted to the RHH oncology units from 1/1/04 to 31112/06 were assessed for symptomatic VTE, Patients were identified for inclusion if they had active cancer, were hospitalised for at least four consecutive days, and aged over 18 years, Results 237 patients were included, 81.4% were eligible to receive thromboprophylaxis according to hospital guidelines, Of these patients, 30,6% received prophylaxis during their hospital stay, The patients who developed VTE had a mean of 5,6 risk factors for VTE, The incidence of symptomatic VTE during the index admission and within 90 days of hospital discharge was 4,2%, Patients with previous history of VTE had a significantly higher risk of a recurrent event (P < 0,01), Of those who developed VTE, 40,0% (4 of 10) received prophylaxis during their index admission,

Item Details

Item Type:Conference Extract
Research Division:Medical and Health Sciences
Research Group:Public Health and Health Services
Research Field:Public Health and Health Services not elsewhere classified
Objective Division:Health
Objective Group:Public Health (excl. Specific Population Health)
Objective Field:Preventive Medicine
UTAS Author:Bereznicki, LRE (Professor Luke Bereznicki)
UTAS Author:Peterson, GM (Professor Gregory Peterson)
UTAS Author:Krog, M (Ms Maria Krog)
UTAS Author:La Rosa, T (Ms Tihana La Rosa)
UTAS Author:Marsden, KA (Dr Katherine Marsden)
UTAS Author:Lowenthal, RM (Professor Ray Lowenthal)
ID Code:52177
Year Published:2008
Deposited By:Pharmacy
Deposited On:2008-06-04
Last Modified:2015-09-07
Downloads:239 View Download Statistics

Repository Staff Only: item control page